BBIO vs ECL
BridgeBio Pharma Inc (BBIO) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BBIO currently screens at market cap $13.24B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BBIO and ECL stock pages for the full models.
Not investment advice.